Sökning: WFRF:(Kahan Thomas)
> Karlsson J. >
Gender-specific ass...
Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment : results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)
-
- Hallberg, Pär (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Klinisk farmakogenomik och osteoporos,Department of Medical Sciences, Uppsala University, Uppsala
-
- Karlsson, J. (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Department of Medical Sciences, Uppsala University, Uppsala
-
- Lind, Lars (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Kardiovaskulär epidemiologi,Department of Medical Sciences, Uppsala University, Uppsala
-
visa fler...
-
- Michaëlsson, Karl, 1959- (författare)
- Uppsala universitet,Ortopedi,Department of Surgical Sciences, Uppsala University, Uppsala
-
- Kurland, Lisa, 1960- (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Department of Medical Sciences, Uppsala University, Uppsala
-
- Kahan, Thomas (författare)
- Karolinska Institutet
-
- Malmqvist, K. (författare)
- Karolinska Institutet
-
- Öhman, K. P. (författare)
- Division of Internal Medicine, Karolinska Institute, Danderyd Hospital, Stockholm; Department of Medicine and Care, Faculty of Health Sciences, Linköping
-
- Nyström, Fredrik, 1963- (författare)
- Östergötlands Läns Landsting,Linköpings universitet,Hälsouniversitetet,Internmedicin,Endokrin- och magtarmmedicinska kliniken US
-
- Liljedahl, Ulrika (författare)
- Uppsala universitet,Molekylär medicin,Department of Medical Sciences, Uppsala University, Uppsala
-
- Syvänen, Ann-Christine (författare)
- Uppsala universitet,Molekylär medicin,Department of Medical Sciences, Uppsala University, Uppsala
-
- Melhus, Håkan (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Klinisk farmakogenomik och osteoporos,Department of Medical Sciences, Uppsala University, Uppsala
-
visa färre...
-
(creator_code:org_t)
- 2006-12-05
- 2004
- Engelska.
-
Ingår i: Clinical Cardiology. - : Wiley. - 0160-9289 .- 1932-8737. ; 27:5, s. 287-290
- Relaterad länk:
-
http://www.ncbi.nlm....
-
visa fler...
-
https://onlinelibrar...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
http://kipublication...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: Studies suggest that endothelin-1 contributes to the pathogenesis of hypertension. A G5665T gene polymorphism of preproendothelin-1 has been shown to be associated with higher blood pressure in overweight patients. No study has yet determined the effect of this polymorphism on the change in blood pressure during antihypertensive treatment.HYPOTHESIS:This study aimed to determine this effect in hypertensive patients with left ventricular (LV) hypertrophy during antihypertensive treatment with either irbesartan or atenolol.METHODS: We determined the preproendothelin-1 genotype using minisequencing in 102 patients with essential hypertension and LV hypertrophy verified by echocardiography, randomized in a double-blind fashion to treatment with either the AT1-receptor antagonist irbesartan or the beta1-adrenoceptor antagonist atenolol.RESULTS:The change in systolic blood pressure (SBP) after 12 weeks of treatment was related to the preproendothelin-1 genotype in men; after adjustment for potential covariates (age, blood pressure, and LV mass index at study entry, dose of irbesartan/atenolol, and type of treatment), those carrying the T-allele responded on average with a more than two-fold greater reduction than those with the G/G genotype (-21.9 mmHg [13.9] vs. -8.9 [2.3], p = 0.007). No significant differences in blood pressure change between G/G and carriers of the T-allele were seen among women.CONCLUSIONS:Our finding suggests a gender-specific relationship between the G5665T preproendothelin-1 polymorphism and change in SBP in response to antihypertensive treatment with irbesartan or atenolol, suggesting the endothelin pathway to be a common mechanism included in the hypertensive action of the drugs.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- Antihypertensive Agents/*pharmacology/therapeutic use
- Atenolol/*pharmacology/therapeutic use
- Biphenyl Compounds/*pharmacology/therapeutic use
- Blood Pressure/*drug effects/*genetics
- Endothelin-1/*genetics
- Female
- Genotype
- Humans
- Hypertension/complications/drug therapy/genetics
- Hypertrophy; Left Ventricular/complications/drug therapy/genetics
- Male
- Middle Aged
- Polymorphism; Genetic
- Research Support; Non-U.S. Gov't
- Sex Factors
- Tetrazoles/*pharmacology/therapeutic use
- Treatment Outcome
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Hallberg, Pär
-
Karlsson, J.
-
Lind, Lars
-
Michaëlsson, Kar ...
-
Kurland, Lisa, 1 ...
-
Kahan, Thomas
-
visa fler...
-
Malmqvist, K.
-
Öhman, K. P.
-
Nyström, Fredrik ...
-
Liljedahl, Ulrik ...
-
Syvänen, Ann-Chr ...
-
Melhus, Håkan
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
Clinical Cardiol ...
- Av lärosätet
-
Uppsala universitet
-
Örebro universitet
-
Karolinska Institutet
-
Linköpings universitet